TP53 and breast cancer: Notably, to address the contribution of wild-type Tp53 in the TME, the Lozano laboratory has developed a Tp53wm-R172H/+ model of breast cancer in which an exogenous Tp53 cDNA is expressed in non-Cre-expressing cells (110).